Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nel ASA Share Issue/Capital Change 2014

Apr 11, 2014

3670_rns_2014-04-11_ba54b19e-c410-4c7b-955d-ae2b1a7d1d89.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Registered share capital increase

Registered share capital increase

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN

OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG OR JAPAN OR SUCH

OTHER JURISDICTIONS WHERE THE OFFERING AND SALE OF THE NEW SHARES AND

THE SUBSCRIPTION RIGHTS IS RESTRICTED BY LAW.

DiaGenic ASA

Reference is made to the stock exchange announcement made by Diagenic

ASA (the "Company") on 4 April 2014 regarding the rights offering (the

"Rights Offering") of 100,000,000 offered shares in DiaGenic ASA at

subscription price NOK 0.50 per share.

The share capital increase pertaining to the private placement has now

been registered with the Norwegian Register of Business Enterprises.

The Company's new registered share capital is NOK 21,631,974.60,

corresponding to a total of 108,159,873 shares with a nominal value of

NOK 0.20 per share.

The new shares issued in the Rights Offering will be listed immediately

on Oslo Børs.

For further information, please contact:

Lars Christian Stugaard, Acting CEO, DiaGenic ASA, tel +47 23 01 49 06

This information is subject of the disclosure requirements acc. to §5-12

vphl (Norwegian Securities Trading Act)